Live Quote · NASDAQHALOHealthcare· Biotechnology

Halozyme Therapeutics, Inc.

$91.35▼ 1.82%($-1.69)
MKT CAP $10.41BNEXT EARNINGS Feb 16, 2027
50%
Bullish
TickerSpark Score
70/100
▌ Solid
70
Valuation
80
Profitability
55
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HALO research report →

Analyst Price Target
$110.67+21.1% vs. today

Range $90 – $130

Analyst RatingBuy
16 Buy10 Hold1 Sell

Price Chart

+32.44% · this period
$131.18$96.41$61.63Nov 19May 22Nov 19
52-Week Range41% of range
Low
$61.23
Current
$91.35
High
$134.00